Tissue Diagnostics: Technologies and Global Markets

Tissue Diagnostics: Technologies and Global Markets



Report Scope

The report provides an analysis of the tissue diagnostics market, along with a competitive landscape and profiles of leading companies that include their revenues, product portfolios and recent activities. The report analyzes market dynamics, including drivers, limitations, challenges and opportunities, and discusses current and potential market size. The report will enable companies in the industry to make informed decisions about the production and licensing of goods and services. Organizations, distributors and exporters should find useful information about market developments and trends.

The study segments the market on multiple bases. By product type, the market is segmented into instruments and reagents (reagents/test kits/consumables of tissue diagnostics).

By segment type, the market is divided into histopathology, which includes hematoxylin and eosin stains (H&E) and immunohistochemistry (IHC); molecular pathology, which includes in situ hybridization (ISH), polymerase chain reaction (PCR) and next-generation sequencing (NGS); microbiological testing, which includes general culture testing and antimicrobial susceptibility testing and identification (AST/ID); and digital pathology.

Regional market analysis is provided for all the major segments. The regions are North America; Europe; Asia-Pacific; Latin America; and Rest of the World (RoW), which in this report consists of the Middle East and Africa. The report also provides country-level analyses of markets and market segments.

The report covers only tissue sample-based tests. The liquid biopsy market; swab, saliva and urine-based tests; and the service testing market of tissue diagnostics are outside the scope of the report.

In this report, the tissue diagnostics market is segmented by:

Product type:

Reagents.

Instruments.

Segments:

Histopathology (H&E, IHC).

Molecular pathology (ISH, PCR and NGS).

Microbiological testing (general culture testing, AST/ID testing) .

Digital pathology.

Technology:

H&E.

IHC.

ISH.

PCR.

NGS.

Digital pathology.

Applications:

Oncology.

Tissue typing.

Pathogen detection and AST.

End users:

Professional laboratories.

Emergency care units.

Academic and research institutes.

Report Includes

40 data tables and 42 additional tables

An analysis of the global market trends for tissue diagnostics, with market revenue data from 2022 to 2023, estimates for 2024, forecasts for 2025, and projected CAGRs through 2029

Estimates of the size and revenue prospects of the global market, along with a market share analysis by type of test, technology, application, end user and region

Facts and figures pertaining to the market dynamics, technical advances, regulations, and the impact of macroeconomic factors

Insights derived from the Porter’s Five Forces model, as well as global supply chain and PESTLE analyses

An analysis of patents, emerging trends and developments in the industry

Analysis of the industry structure, including companies’ market shares and rankings, strategic alliances, M&A activity and a venture funding outlook

Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies

Company profiles of major players within the industry, including F. Hoffmann-La Roche Ltd., Danaher Corp., Agilent Technologies Inc., Thermo Fisher Scientific Inc., and Illumina Inc.

Companies Mentioned

Abbott
Agilent Technologies Inc.
Bd
Biocare Medical Llc.
Biomerieux
Bio-rad Laboratories Inc.
Danaher Corp.
F. Hoffmann-la Roche Ltd.
Illumina Inc.
Koninklijke Philips N.V.
Merck Kgaa
Myriad Genetics Inc.
Qiagen
Thermo Fisher Scientific Inc.
Zytovision Gmbh


Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Market Overview and Definitions
Immunohistochemistry (IHC)
In Situ Hybridization
Polymerase Chain Reaction
Next-Generation Sequencing
General Culture Testing
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Increasing Incidence of Cancer Cases
Companion Diagnostics in Cancer Treatment
Importance of Early Cancer Testing
Raising Awareness of Early Signs of Cancer
Aging Population
Market Opportunities
Enhancing Access
Digital Pathology
Partnerships
Market Restraints
Cost of Tissue Diagnostic Tests
Competing Technologies
Turnaround Time
Market Challenges
Lack of Skilled Professionals
Complex Sample Preparation and Handling
Chapter 4 Emerging Technologies and Developments
Overview
Digital Pathology and AI Integration
3D Tissue Pathology and AI
Fluorescent In Situ Sequencing
Chapter 5 Tissue Diagnostics Testing Market
Segmentation Breakdown
Market Breakdown
Market Breakdown, by Product Type
Market Breakdown, by Technology
Market Breakdown, by Segment
Histopathology Market
Molecular Pathology Market
Microbiology Testing Market
Digital Pathology Market
Market Breakdown, by Application
Market Breakdown, by End User
Geographic Breakdown
Market Breakdown, by Region
North America
Europe
Asia-Pacific
Latin America
Rest of the World
Chapter 6 Competitive Intelligence
Industry Scenario
Competitive Landscape
Chapter 7 Sustainability in the Market for Tissue Diagnostics: An ESG Perspective
Introduction to ESG
Environmental Performance
Social Performance
Governance Performance
Concluding Remarks from BCC
Chapter 8 Appendix
Research Methodology
References
Acronyms
Company Profiles
ABBOTT
AGILENT TECHNOLOGIES INC.
BD
BIOCARE MEDICAL LLC.
BIOMERIEUX
BIO-RAD LABORATORIES INC.
DANAHER CORP.
F. HOFFMANN-LA ROCHE LTD.
ILLUMINA INC.
KONINKLIJKE PHILIPS N.V.
MERCK KGAA
MYRIAD GENETICS INC.
QIAGEN
THERMO FISHER SCIENTIFIC INC.
ZYTOVISION GMBH

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings